Lv11
50 积分 2023-02-28 加入
[Guidelines for the diagnosis and management of multiple myeloma in China (2024 revision)]
1小时前
待确认
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial
12天前
已完结
Updated Diagnostic Criteria and Staging System for Multiple Myeloma
1个月前
已完结
Phase I Trial of MCARH109, a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
2个月前
已完结
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
3个月前
已完结
Recovery-model: A model for CAR T-cell-related thrombocytopenia in relapsed/refractory multiple myeloma
4个月前
已完结
Multiple myeloma
6个月前
已完结
GPRC5D-Targeted CAR T Cells for Myeloma. Reply
1年前
已完结
Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience
1年前
已完结
Naturally Selected CD7 CAR-T Therapy without Genetic Manipulations for T-ALL/LBL: First-in-human Phase I Clinical Trial
1年前
已完结
皖公网安备34019202002308
